Mesoblast (MESO) Gross Profit (2016 - 2023)

Mesoblast has disclosed Gross Profit across 8 years of filings, most recently posting $328.8 million for Q2 2023.

• Gross Profit for Q2 2023 came in at $328.8 million, up 7.17% year-over-year; the trailing twelve-month figure through Jun 2023 was -$129.1 million (down 33.71% YoY), and the FY2025 annual result was $12.1 million, changed N/A from the prior year.
• Gross Profit came in at $328.8 million for Q2 2023 at Mesoblast, up from -$121.5 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $341.6 million in Q2 2021 to a low of -$250.8 million in Q3 2022.
• The 5-year median for Gross Profit is -$67.0 million (2019), against an average of $766888.9.
• Across the five-year window, Gross Profit jumped 46937.01% in 2020 and tumbled 4208.34% in 2021, its largest moves.
• Mesoblast's Gross Profit stood at -$84.4 million in 2019, then soared by 95.01% to -$4.2 million in 2020, then sank by 4208.34% to -$181.3 million in 2021, then jumped by 52.78% to -$85.6 million in 2022, then surged by 484.02% to $328.8 million in 2023.
• The last three Gross Profit figures came in at $328.8 million (Q2 2023), -$121.5 million (Q1 2023), and -$85.6 million (Q4 2022), per Business Quant data.